Effect of Liraglutide Combined With Short-term CSII on Long-term Glycemic Remission and β Cell Function
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate and evaluate the effects of liraglutide combined
with short-term continuous subcutaneous insulin infusion(CSII) on long-term glycemic control
and β-cell function in newly diagnosed type 2 diabetic patients.